🎉 Free to use until Sep 16, 2026 — try it out for our launch!
S&P 5007,709.96 0.18%
Dow Jones53,885.1 0.85%
Nasdaq26,348.35 0.06%
Russell 20003,001.55 0.58%
Fear Index (VIX)15.28 0.86%
TA-125₪4,050.34 0.44%
S&P 5007,709.96 0.18%
Dow Jones53,885.1 0.85%
Nasdaq26,348.35 0.06%
Russell 20003,001.55 0.58%
Fear Index (VIX)15.28 0.86%
TA-125₪4,050.34 0.44%

PGNY

Progyny Inc. Common Stock

Health Care · ·

$30.21

$1.16 (-3.7%)

Market Cap

$2.37B

Day Range

$30.15 - $31.43

52-Week Range

$16.10 - $33.07

Beta

Next Earnings

04.11.2026

PGNY is a stock from the Healthcare sectorPharmaceuticals, biotech, medical devices, and health insurance — less sensitive to economic cycles, but exposed to regulation and FDA approvals.

🏢 Similar Stocks in the Same Sector

+31.0% (1Y)

Investor Score
62/ 100C+
🟡 Moderate

This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer

📈58CTechnical
💰56CFundamental
🚀67B-Growth
💎57CValuation
📰86ANews
🏦58CQuality
⚠️56CRisk

Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%

🔍 Cross-Check

Overall Score

🟡 Mixed

Technical Trend

🟡 Mixed

Insiders

🔴 Bearish

✅ Why is the score relatively high?

  • 🟢 Estimated fair value: $47.86 vs. price $30.21 (+58.4%)
  • 🟢 SMA 50 recently crossed above SMA 200
  • 🟢 Operating margin is stable or improving over time
  • 🟢 Current ratio: 2.73
  • 🟢 Price is above the 50-day average

⚠️ What's concerning?

  • 🔴 MACD histogram is negative — falling momentum
  • 🔴 P/E: 46.5
  • 🔴 Price is below the SAR point — downtrend
  • 🔴 %K 10.1 — oversold
  • 🔴 ROC 12 days: -6.3%

🚦 Quality & Risk Checks

🟢 Operating margin stability🟡 Daily volatility (ATR)🟢 Liquidity risk

📰 News Trend

Based on real financial news (Finnhub)
🟢 Positive

Everyone's writing about Progyny Inc. Common Stock. News trend score: 86. Reason: 9 of the last 20 articles are positive, versus 3 negative.

News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer

📈 Technical Analysis

Based on the last 251 trading days, calculated from real price data. Click an indicator for details and a chart.

🟡 Indicators are mixed — no clear bias (5 bullish · 6 bearish · 1 neutral)

Conclusions

  • 🟢Price vs. SMA 50Price is above the 50-day average
  • 🟢Price vs. SMA 200Price is above the 200-day average
  • 🟢Golden CrossSMA 50 recently crossed above SMA 200
  • 🔴MACDMACD histogram is negative — falling momentum
  • 🔴RSIRSI 47.5 — weak/negative bias
  • 🔴Stochastic%K 10.1 — oversold
  • 🟢ADX (trend strength)ADX 38.5 — strong trend
  • 🟢Relative strength vs. S&P 500+56.8% over the last 3 months relative to the index
  • 🔴Bollinger BandsPrice is in the lower third of the Bollinger Bands (-5%B) — weakness (chance of a recovery)
  • 🔴ROC (rate of change)ROC 12 days: -6.3%
  • 🔴Parabolic SARPrice is below the SAR point — downtrend
  • 🟡CMF (money flow)CMF 20 days: -0.01

Wyckoff Method Analysis

A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.

Markup

The stock is in a clear uptrend with no defined trading range in the period examined.

Medium confidence

Evidence Behind This Read

  • 🟢Rising price trendA 18.6% change over the last 50 days, with no defined trading range.

The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.

🎯 Trade Planning (M.A.E.E Framework)

Based on a mechanical trading method: market structure → value zone → ATR-based exit point. Not investment advice — a calculation tool only.

1️⃣ Market Structure

🟢 Uptrend

The price is above the 200-day average — per the market-structure method, this environment mainly favors looking for buying (Long) opportunities.

2️⃣ Value Zone

🟡 Price far from value zone

The price is currently far from the 50-day average — the method recommends waiting for a "pullback" before entering, rather than chasing prices.

3️⃣ Suggested Exit Point (ATR-based)

Method formula: Stop-loss = support minusone ATR margin — this way the stop adapts to the stock's actual volatility, rather than an arbitrary number.

Entry

$30.21

Stop-Loss

$23.59

Risk per Share

$6.62

Direction

Long

Profit Targets by Risk/Reward Ratio (R)

1:2 R

$43.45

1:3 R

$50.07

1:5 R

$63.31

💰 Position Size Calculator

A core principle of the method: never risk a fixed dollar amount — risk a fixed percentage of equity, and let the position size vary according to the risk per share.

Suggested Position Size

15 sh.

💰 Financial Health

Profitability

Gross Margin

23.6%

Operating Margin

6.6%

Net Margin

4.5%

EBITDA Margin

7.0%

Efficiency

ROE

11.3%

ROA

7.9%

ROIC

EPS

$0.68

Balance Sheet

Cash

$112.24M

Total Debt

Current Ratio

2.73

Debt/Equity

Conclusions

  • 🟡Gross marginGross margin: 23.6% — reasonable
  • 🔴Operating marginOperating margin: 6.6% — weak
  • 🔴Net marginNet margin: 4.5% — weak
  • 🟡Return on equity (ROE)Return on equity (ROE): 11.3% — reasonable
  • 🟡Return on assets (ROA)Return on assets (ROA): 7.9% — reasonable
  • 🟢Current ratio (liquidity)Current ratio: 2.73

🚀 Growth

Revenue

Earnings per Share (EPS)

Net Income

Free Cash Flow (FCF)

Conclusions

  • 🟢Revenue growth (last year)Revenue growth (last year): 10.4%
  • 🟢Earnings per share (EPS) growthEarnings per share (EPS) growth: 14.0%
  • 🟢Free cash flow growthFree cash flow growth: 10.4%
  • 🟡Net income growthNet income growth: 7.7%

💎 Fair Value (Valuation)

Current Price

$30.21

Estimated Fair Value (DCF)

$47.86

Gap

+58.4%

🟢 Appears cheap relative to estimated value

Show all model (DCF) assumptions →

Year 1 Growth Rate

18.7%

Discount Rate (WACC)

9.0%

Terminal Growth Rate

2.5%

Projection Years

5

YearGrowth RateProjected FCFPresent Value
118.7%$227.56M$208.77M
214.6%$260.82M$219.53M
310.6%$288.41M$222.70M
46.5%$307.26M$217.67M
52.5%$314.95M$204.69M

Base FCF (last actual year)

$191.78M

Terminal Value

$4.97B

Present Value of Terminal Value

$3.23B

Enterprise Value

$4.30B

Net Debt

$0

Equity Value

$4.30B

*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.

Book Value per Share

$5.74

Tangible Book Value per Share (Tangible NAV)

$5.45

Conclusions

  • 🟢DCF Fair ValueEstimated fair value: $47.86 vs. price $30.21 (+58.4%)
  • 🟡Tangible Net Asset Value (NAV)NAV per share: $5.45
  • 🔴P/EP/E: 46.5

🕴️ Insider Trading

Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 10 sales out of the last 25 filings.

NameTransaction TypeDateSharesChangePrice
Cummings Melissa BTax Withholding in Shares14.7.202672,178-1,193$31.98
Cummings Melissa BOpen Market Sale14.7.202669,934-2,244$31.60
Clapp GeoffreyTax Withholding in Shares17.6.202659,828-819$26.60
Swartz AllisonTax Withholding in Shares4.6.202682,977-339$24.99
Swartz AllisonOpen Market Sale4.6.202682,378-599$25.08
Livingston Mark S.Tax Withholding in Shares4.6.202677,205-339$24.99
Livingston Mark S.Open Market Sale4.6.202675,287-1,918$25.50
Livingston Mark S.Open Market Sale4.6.202674,688-599$25.50
Anevski PeterTax Withholding in Shares3.6.2026811,472-5,361$25.12
Swartz AllisonTax Withholding in Shares3.6.202684,515-676$25.12
Swartz AllisonOpen Market Sale3.6.202683,316-1,199$25.02
Livingston Mark S.Tax Withholding in Shares3.6.202677,544-1,082$25.12
Clapp GeoffreyOpen Market Sale2.6.202659,117-1,530$25.58
Clapp GeoffreyExercise of Derivative Securities2.6.202672,026+12,909$20.91
Clapp GeoffreyTax Withholding in Shares2.6.202660,647-11,379$25.54
Clapp GeoffreyExercise of Derivative Securities2.6.202626,211-12,909
Livingston Mark S.Tax Withholding in Shares2.6.202678,905-158$26.20
Livingston Mark S.Open Market Sale2.6.202678,626-279$26.20
Scott CherylExercise of Derivative Securities1.6.202634,439+14,667$13.00
Scott CherylTax Withholding in Shares1.6.202627,211-7,228$26.38
Scott CherylOpen Market Sale1.6.202619,772-7,439$26.39
Scott CherylExercise of Derivative Securities1.6.202629,333-14,667
Swartz AllisonTax Withholding in Shares28.5.202687,589-1,352$25.48
Swartz AllisonOpen Market Sale28.5.202685,191-2,398$25.46
GORDON KEVIN KOpen Market Sale27.5.20269,318-5,500$24.99

📉 Short Interest

Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.

Monthly Trend — Open Short Interest

+3.0%

4,629,299 shares short as of 2026-07-15 · vs. 4,493,605 on 2026-06-30

Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.

Weekly Trend — Daily Short-Sale Activity

-24.1%

44.0% of trading volume this week was short selling, vs. 58.0% the prior week

Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.

📰 News & Sentiment

Sentiment based on basic keywords (not AI) — 9 positive, 8 neutral, 3 negative out of the last 20 articles.